Effect of caldesmon mutations in the development of zebrafish embryos

dc.contributor.authorVirtanen Verneri
dc.contributor.authorPaunu Kreetta
dc.contributor.authorNiva Saana
dc.contributor.authorSundvall Maria
dc.contributor.authorPaatero Ilkka
dc.contributor.organizationfi=Turun biotiedekeskus|en=Turku Bioscience Centre|
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=kliininen syöpätautioppi|en=Clinical Oncology|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.18586209670
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.contributor.organization-code2607315
dc.converis.publication-id179842996
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/179842996
dc.date.accessioned2025-08-27T22:17:53Z
dc.date.available2025-08-27T22:17:53Z
dc.description.abstractCancer is a profound medical concern and better treatments are needed for cancer patients. Therefore, new cancer targets are constantly being studied. These targets need not only be relevant for cancer progression, but their modulation needs to be tolerated reasonably well by the host. Caldesmon is one of these proposed novel targets for cancer therapy. Therefore, we analyzed effects of caldesmon mutations in normal development using genetically modified zebrafish embryos. We analyzed mutations in both zebrafish caldesmon genes, cald1a and cald1b and analyzed effects of either mutation alone or as in combination in double homozygous embryos using molecular, morphological and functional analyses. The effects of caldesmon mutations were mild and the gross development of zebrafish embryos was normal. The caldesmon mutant embryos had, however, alterations in response to light-stimulus in behavioural assays. Taken together, the effects of caldesmon mutations in the development of zebrafish embryos were reasonably well tolerated and did not indicate significant concerns for caldesmon being a potential target for cancer therapy.
dc.format.pagerange10
dc.format.pagerange18
dc.identifier.eissn1090-2104
dc.identifier.jour-issn0006-291X
dc.identifier.olddbid201927
dc.identifier.oldhandle10024/184954
dc.identifier.urihttps://www.utupub.fi/handle/11111/34017
dc.identifier.urlhttps://doi.org/10.1016/j.bbrc.2023.05.079
dc.identifier.urnURN:NBN:fi-fe2025082785560
dc.language.isoen
dc.okm.affiliatedauthorVirtanen, Verneri
dc.okm.affiliatedauthorPaunu, Kreetta
dc.okm.affiliatedauthorNiva, Saana
dc.okm.affiliatedauthorSundvall, Maria
dc.okm.affiliatedauthorPaatero, Ilkka
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3122 Cancersen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.discipline3122 Syöpätauditfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.doi10.1016/j.bbrc.2023.05.079
dc.relation.ispartofjournalBiochemical and Biophysical Research Communications
dc.relation.volume669
dc.source.identifierhttps://www.utupub.fi/handle/10024/184954
dc.titleEffect of caldesmon mutations in the development of zebrafish embryos
dc.year.issued2023

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
1-s2.0-S0006291X23006575-main.pdf
Size:
2.63 MB
Format:
Adobe Portable Document Format